Specialist Orthopaedic Oncology Services

{
  "awards": [
    {
      "id": "086009-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-170104",
          "name": "Birmingham Orthopaedic Oncology LLP"
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      },
      {
        "id": "2",
        "measure": "smeBids",
        "relatedLot": "1",
        "value": 1
      },
      {
        "id": "3",
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1",
        "value": 1
      }
    ]
  },
  "buyer": {
    "id": "GB-FTS-24918",
    "name": "The Royal Orthopaedic Hospital NHS Foundation Trust"
  },
  "contracts": [
    {
      "awardID": "086009-2025-1",
      "dateSigned": "2025-12-23T00:00:00Z",
      "id": "086009-2025-1",
      "status": "active",
      "value": {
        "amount": 200000.0,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-12-23T17:19:41Z",
  "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 8th January 2026. This contract has not yet been formally awarded; this notice serves and as an intention to award under the PSR\u003cbr/\u003e\u003cbr/\u003eAny written representation should be sent to matthew.kelsall@uhb.nhs.uk and paul.lee@uhb.nhs.uk\u003cbr/\u003e\u003cbr/\u003eThe award decision makers in respect of this award are: Steve Washbourne - Executive Chief Financial Officer and Marie Peplow - Chief Operating Officer.\u003cbr/\u003e\u003cbr/\u003eConflicts of Interest Declarations have been received and no conflicts have been identified in respect of the proposed award.\u003cbr/\u003e\u003cbr/\u003eThe Trust has awarded this contract using Direct Award Process C under the Provider Selection Regime (PSR) on the basis that the provider is already delivering this service to the required standard and remains the most appropriate organisation to continue doing so.\u003cbr/\u003eOn this basis, the Trust has determined that:\u003cbr/\u003e\u003cbr/\u003ethe provider continues to be suitable and capable of delivering the service;\u003cbr/\u003e\u003cbr/\u003ethere is no evidence that an alternative provider would deliver better value, outcomes or performance; and\u003cbr/\u003e\u003cbr/\u003ea competitive process would not be proportionate or in the best interests of patients or the Trust.\u003cbr/\u003e\u003cbr/\u003eAccordingly, the Trust is satisfied that award through PSR Direct Award Process C is justified, compliant and in the best interests of service continuity, patient care, value and system stability.\u003cbr/\u003e\u003cbr/\u003eThe provider has demonstrated consistent high-quality clinical delivery, compliance with contractual requirements and strong engagement with the Trust\u2019s governance, quality and safety processes. They have established and effective working relationships with Trust clinicians and operational teams and are fully embedded within existing pathways, ensuring safe, coordinated and efficient patient care.\u003cbr/\u003e\u003cbr/\u003eContinuity of service is critical for patient outcomes, workforce stability and operational resilience. This provider offers a stable, experienced and clinically credible service model, with an appropriately skilled workforce, robust clinical governance arrangements and proven ability to meet activity, safety and performance requirements. Transitioning the service to an alternative provider would introduce unnecessary risk, potential disruption and avoidable cost without any evidence of improvement in quality or value.\u003cbr/\u003e\u003cbr/\u003eThe proposed contractual arrangements are affordable, represent value for money, and are aligned to the Trust\u2019s financial framework, activity requirements and strategic objectives. The provider has demonstrated capability to continue delivery safely, sustainably and in line with national standards, Trust policies and NHS contractual expectations.\u003cbr/\u003e\u003cbr/\u003eIn reaching the decision to award this contract, the Trust undertook a structured assessment of the key criteria and the basic selection criteria, in line with the requirements of the Provider Selection Regime (Direct Award Process C).\u003cbr/\u003e\u003cbr/\u003eThe Trust first confirmed that the provider continued to meet all basic eligibility requirements, including regulatory compliance, clinical governance arrangements, indemnity, safeguarding requirements, data protection obligations and adherence to Trust policies. This included assurance that the provider\u2019s workforce remained appropriately qualified, registered and competent to deliver the service safely.\u003cbr/\u003e\u003cbr/\u003eThe Trust then assessed the provider against the key PSR decision-making criteria, using a balanced and proportionate approach focused on:\u003cbr/\u003e\u003cbr/\u003eQuality and clinical governance \u2013 performance against existing contractual quality requirements, evidence of safe delivery, participation in governance, learning from incidents and complaints, and alignment to national standards and Trust expectations.\u003cbr/\u003e\u003cbr/\u003eValue \u2013 affordability, transparency of costs, alignment with Trust financial plans and evidence that the service continues to represent value for money over the contract term.\u003cbr/\u003e\u003cbr/\u003eIntegration, collaboration and sustainability \u2013 effectiveness of partnership working with Trust teams, alignment with Trust pathways and operational processes, and assurance around service resilience, business continuity and workforce sustainability.\u003cbr/\u003e\u003cbr/\u003eAccess and inequalities \u2013 ability to support timely access, equitable service delivery and compliance with Trust responsibilities relating to equality, inclusion and patient need.\u003cbr/\u003e\u003cbr/\u003eSocial value and alignment with NHS values \u2013 workforce wellbeing, ethical and responsible service delivery and contribution to wider NHS and Trust priorities where relevant.\u003cbr/\u003e\u003cbr/\u003eNo artificial numerical weighting was applied, as the assessment was based on whether the provider continued to demonstrably meet required standards and offered the most appropriate solution for safe, stable and effective service delivery. However, quality, safety, continuity of care and service resilience were given greatest priority, reflecting the clinical nature of the service and associated risk if delivery failed or transferred unnecessarily.\u003cbr/\u003e\u003cbr/\u003eThrough this assessment, the Trust was satisfied that:\u003cbr/\u003e\u003cbr/\u003ethe provider continues to meet all basic selection criteria,\u003cbr/\u003e\u003cbr/\u003ethe provider continues to meet the PSR key decision-making criteria to a high and acceptable standard, and\u003cbr/\u003e\u003cbr/\u003eno evidence exists to suggest that an alternative provider would deliver improved outcomes, better value or reduced risk.\u003cbr/\u003e\u003cbr/\u003eOn that basis, the Trust concluded that the provider remains the most appropriate organisation to deliver the service and that proceeding via Direct Award Process C was proportionate, justified and in the best interests of patients, quality, value and service continuity.",
  "id": "086009-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05fcf7",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Birmingham",
        "postalCode": "B31 2AP",
        "region": "UKG3",
        "streetAddress": "Bristol Road South"
      },
      "contactPoint": {
        "email": "matthew.kelsall@uhb.nhs.uk",
        "name": "Matthew Kelsall"
      },
      "details": {
        "buyerProfile": "https://www.uhb.nhs.uk/",
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://www.uhb.nhs.uk/"
      },
      "id": "GB-FTS-24918",
      "identifier": {
        "legalName": "The Royal Orthopaedic Hospital NHS Foundation Trust"
      },
      "name": "The Royal Orthopaedic Hospital NHS Foundation Trust",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Hailsham",
        "postalCode": "BN27 1AE",
        "region": "UKG3",
        "streetAddress": "Cortlandt, George Street"
      },
      "details": {
        "scale": "sme"
      },
      "id": "GB-FTS-170104",
      "identifier": {
        "legalName": "Birmingham Orthopaedic Oncology LLP"
      },
      "name": "Birmingham Orthopaedic Oncology LLP",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Birmingham",
        "postalCode": "B15 2GW",
        "streetAddress": "Queen Elizabeth Hospital Birmingham"
      },
      "details": {
        "url": "https://www.uhb.nhs.uk/"
      },
      "id": "GB-FTS-108440",
      "identifier": {
        "legalName": "University Hospitals Birmingham NHS Foundation Trust"
      },
      "name": "University Hospitals Birmingham NHS Foundation Trust",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Orthopaedic services",
      "id": "85121283",
      "scheme": "CPV"
    },
    "description": "The provision of specialist Orthopaedic Oncology Services",
    "id": "PROC.01.0039C",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Surgical specialist services",
            "id": "85121300",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKG3"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "type": "price"
            }
          ]
        },
        "description": "This contract is for the provision of specialist Orthopaedic Oncology Services for patients of The Royal Orthopaedic Hospital.\u003cbr/\u003e\u003cbr/\u003eThe Authority intends to award this contract to the existing provider following the Direct Award C process under the Provider Selection Regime 2023.\u003cbr/\u003e\u003cbr/\u003eThe initial terms of the contract shall run from 9th January 2026 until 8th January 2027. There will be an option to extend the contract for a further 12 months.\u003cbr/\u003e\u003cbr/\u003eThe approximate lifetime value of the contract if extended will be \u00a3200,000",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 8th January 2026. This contract has not yet been formally awarded; this notice serves and as an intention to award under the PSR",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The procurement falls outside the scope of application of the directive",
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "status": "complete",
    "title": "Specialist Orthopaedic Oncology Services"
  }
}